アメリカのペイシェント・エクスペリエンス(PX)技術市場(~2026年):コンポーネント別(技術(患者ラウンディング、患者体験調査)、コンサルティングサービス)、施設種類別(急性期治療、急性期後治療、非急性期治療(医師室、クリニック))

【英語タイトル】Patient Experience Technology Market by Component (Technology (Patient Rounding, Patient experience survey), Consulting Services) & Facility Type (Acute Care, Post Acute Care, Non Acute Care (Physicians Office, Clinics)) - US Forecasts to 2026

MarketsandMarketsが出版した調査資料(HIT 8057-22)・商品コード:HIT 8057-22
・発行会社(調査会社):MarketsandMarkets
・発行日:2022年3月15日
・ページ数:88
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後24時間以内)
・調査対象地域:アメリカ
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD4,950 ⇒換算¥732,600見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥984,200見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥1,206,200見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

マーケッツアンドマーケッツ社は、アメリカのペイシェント・エクスペリエンス(PX)技術市場規模が2021年179百万ドルから2026年299百万ドルまで、年平均10.7%成長すると予想しています。本市場調査資料では、ペイシェント・エクスペリエンス(PX)技術のアメリカ市場を調査対象とし、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、コンポーネント別(技術、コンサルティングサービス)分析、施設種類別(急性期治療施設、急性期後治療施設、非急性期治療施設)分析、競争状況、企業情報などを整理しました。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・アメリカのペイシェント・エクスペリエンス(PX)技術市場規模:コンポーネント別(技術、コンサルティングサービス)
・アメリカのペイシェント・エクスペリエンス(PX)技術市場規模:施設種類別(急性期治療施設、急性期後治療施設、非急性期治療施設)
・競争状況
・企業情報

“The US patient experience technology market is projected to reach USD 299 million by 2026 from USD 179 million in 2021, at a CAGR of 10.7% during the forecast period.”
Growth in this market is driven by factors such as the favorable government regulations and initiatives to promote the adoption of HCIT solutions, the advantages of patient rounding solutions, and the growing number of collaborations and partnerships between stakeholders.
However, factors such as the high investments for IT infrastructure and the shortage of skilled IT professionals in the healthcare industry are expected to restrain the growth of this market to a certain extent during the forecast period.

“Technology segment is expected to grow at the highest rate during the forecast period.”
Based on components, the US patient experience technology market is segmented into technology and consulting services. The technology segment accounted for the largest share of the US patient experience technology market in 2020. It is also estimated to grow at the highest CAGR during the forecast period, as technology is an indispensable part of the patient experience journey.

“Acute Care Facilities segment is estimated to account for the largest share of the US patient experience technology market in 2020.”
Based on facility types, the US patient experience technology market is segmented into acute care, post-acute care, and non-acute care facilities. Acute care facilities accounted for the largest share of the US patient experience technology market in 2020. This can be attributed to the increased adoption of patient experience solutions by acute hospitals, the rapidly growing geriatric population, and the growing adoption of patient-centric care in acute hospitals.

Breakdown of supply-side primary interviews, by company type, designation, and region:
• By Company Type: Tier 1 (41%), Tier 2 (31%), and Tier 3 (28%)
• By Designation: C-level (44%), Director-level (35%), and Others (21%)
• By Demand Side: Hospital (41%), Payer (34%), Government institute (25%)

Some major players in the US patient experience technology market are Sodexo (France), Press Ganey Associates (US), Vocera Communications (US), Huron Consulting Group (US), Aramark (US), CipherHealth (US), Accenture (US), Qualtrics (US), GetWell (US), and HybridChart (US).

Research Coverage:
• The report studies the US patient experience technology market based on component and facility type.
• The report analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth
• The report evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders
• The report studies micro-markets with respect to their growth trends, prospects, and contributions to the US patient experience technology market
• The report forecasts the revenue of market segments with respect to US region

Key Benefits of Buying the Report:
The report will help the leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall market and the sub-segments. This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the US patient experience technology market and provides them information on key market drivers, restraints, challenges, and opportunities.

❖ レポートの目次 ❖

1 INTRODUCTION 13
1.1 OBJECTIVES OF THE STUDY 13
1.2 MARKET DEFINITION 14
1.2.1 US PATIENT EXPERIENCE TECHNOLOGY MARKET:
INCLUSIONS & EXCLUSIONS 14
1.3 MARKET SCOPE 15
1.3.1 MARKETS COVERED 15
1.3.2 YEARS CONSIDERED FOR THE STUDY 15
1.4 CURRENCY 16
1.5 LIMITATIONS 16
1.5.1 SCOPE-RELATED LIMITATIONS 16
1.5.2 METHODOLOGY-RELATED LIMITATIONS 16
1.6 STAKEHOLDERS 16
2 RESEARCH METHODOLOGY 17
2.1 RESEARCH DATA 17
FIGURE 1 RESEARCH DESIGN 17
2.1.1 SECONDARY DATA 17
2.1.1.1 Key data from secondary sources 18
2.1.2 PRIMARY RESEARCH 18
FIGURE 2 PRIMARY SOURCES 19
2.1.2.1 Key industry insights 20
2.1.2.2 Breakdown of primary interviews 20
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE
(SUPPLY AND DEMAND SIDE) AND DESIGNATION 20
2.2 MARKET SIZE ESTIMATION METHODOLOGY 21
FIGURE 4 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 21
2.3 TOP-DOWN & BOTTOM-UP APPROACHES 22
FIGURE 5 RESEARCH METHODOLOGY: MARKET ESTIMATION 22
FIGURE 6 MARKET SIZE ESTIMATION METHODOLOGY (TOP-DOWN APPROACH): SEGMENTAL ANALYSIS 23
2.4 MARKET DATA ESTIMATION AND TRIANGULATION 24
FIGURE 7 DATA TRIANGULATION METHODOLOGY 24
2.5 ASSUMPTIONS FOR THE STUDY 25
2.6 RISK ASSESSMENT 25
TABLE 1 RISK ASSESSMENT: US PATIENT EXPERIENCE TECHNOLOGY MARKET 25
2.7 LIMITATIONS 25

3 EXECUTIVE SUMMARY 26
FIGURE 8 US PATIENT EXPERIENCE TECHNOLOGY MARKET, BY COMPONENT,
2021 VS. 2026 (USD MILLION) 26
FIGURE 9 US PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FACILITY TYPE,
2021 VS. 2026 (USD MILLION) 27
4 PREMIUM INSIGHTS 28
4.1 US PATIENT EXPERIENCE TECHNOLOGY MARKET OVERVIEW 28
FIGURE 10 FAVORABLE GOVERNMENT REGULATIONS AND THE ADVANTAGES OF PATIENT ROUNDING SOLUTIONS ARE KEY FACTORS DRIVING MARKET GROWTH 28
4.2 US PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FACILITY TYPE 29
FIGURE 11 ACUTE CARE FACILITIES TO DOMINATE THE US PATIENT EXPERIENCE TECHNOLOGY MARKET DURING THE FORECAST PERIOD 29
4.3 US PATIENT EXPERIENCE TECHNOLOGY MARKET, BY COMPONENT
AND FACILITY TYPE (2021) 30
FIGURE 12 THE TECHNOLOGY SEGMENT ACCOUNTED FOR THE LARGEST SHARE
OF THE US PATIENT EXPERIENCE TECHNOLOGY MARKET IN 2021 30
5 MARKET OVERVIEW 31
5.1 INTRODUCTION 31
5.2 MARKET DYNAMICS 31
FIGURE 13 US PATIENT EXPERIENCE TECHNOLOGY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 31
5.2.1 DRIVERS 32
5.2.1.1 Favorable government regulations and initiatives to promote the adoption of HCIT solutions 32
5.2.1.2 Advantages of patient rounding solutions 32
5.2.1.3 Growing number of collaborations and partnerships between stakeholders 32
5.2.2 RESTRAINTS 33
5.2.2.1 High initial investments for IT infrastructure 33
5.2.2.2 Shortage of skilled IT professionals in the healthcare industry 33
5.2.3 OPPORTUNITIES 34
5.2.3.1 Proven benefits of patient experience solutions in improving the financial performance of hospitals 34
5.2.3.2 Technological advancements 34
5.2.4 CHALLENGES 34
5.2.4.1 Issues related to data security 34
5.3 IMPACT OF COVID-19 ON THE US PATIENT EXPERIENCE TECHNOLOGY MARKET 35
6 US PATIENT EXPERIENCE TECHNOLOGY MARKET, BY COMPONENT 36
6.1 INTRODUCTION 37
TABLE 2 US PATIENT EXPERIENCE TECHNOLOGY MARKET, BY COMPONENT
2019–2026 (USD MILLION) 37

6.2 TECHNOLOGY 37
TABLE 3 US PATIENT EXPERIENCE TECHNOLOGY MARKET, BY TYPE,
2019–2026 (USD MILLION) 37
6.2.1 PATIENT ROUNDING 38
6.2.1.1 Patient rounding improves patient satisfaction scores in healthcare organizations—a key factor driving market growth 38
6.2.2 PATIENT EXPERIENCE SURVEYS 38
6.2.2.1 Patient experience surveys convert subjective reviews into quantifiable and meaningful data—a key factor driving market growth 38
6.3 CONSULTING SERVICES 38
6.3.1 CONSULTING SERVICES PROVIDE EXPERT CONSULTANCY TO ENSURE SOLUTIONS AND PROCESS OPTIMIZATION 38
7 US PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FACILITY TYPE 39
7.1 INTRODUCTION 40
TABLE 4 US PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FACILITY TYPE,
2019–2026 (USD MILLION) 40
7.2 ACUTE CARE FACILITIES 40
TABLE 5 US PATIENT EXPERIENCE TECHNOLOGY MARKET FOR ACUTE CARE FACILITIES, BY TYPE, 2019–2026 (USD MILLION) 41
7.2.1 ACUTE HOSPITALS 41
7.2.1.1 Growing prevalence of chronic diseases and subsequent growth in patient volumes in acute hospitals to drive market growth 41
7.2.2 CHILDREN’S HOSPITALS 41
7.2.2.1 Increasing number of children’s hospitals taking efforts to provide quality medical care as well as entertainment for children—a key factor driving market growth 41
7.2.3 ACADEMIC MEDICAL CENTERS 42
7.2.3.1 Better communication with medical students to drive the adoption of patient experience solutions in academic medical centers 42
7.2.4 MILITARY TREATMENT FACILITIES 42
7.2.4.1 Military Health System offers healthcare benefits and services through programs—a key factor driving market growth 42
7.2.5 AMBULATORY SURGERY CENTERS 43
7.2.5.1 Adoption of patient experience surveys leading to improved performance of ASCs to growth market growth 43
7.3 POST-ACUTE CARE FACILITIES 43
TABLE 6 US PATIENT EXPERIENCE TECHNOLOGY MARKET FOR POST-ACUTE CARE FACILITIES, BY TYPE, 2019–2026 (USD MILLION) 43
7.3.1 LONG-TERM ACUTE FACILITIES 44
7.3.1.1 Long-term acute facilities are the fastest-growing treatment facilities for the elderly 44
7.3.2 SKILLED NURSING FACILITIES 44
7.3.2.1 Increasing number of skilled nursing facilities will drive the growth of the market 44
7.3.3 OTHER POST-ACUTE CARE FACILITIES 44

7.4 NON-ACUTE CARE FACILITIES 45
TABLE 7 US PATIENT EXPERIENCE TECHNOLOGY MARKET FOR NON-ACUTE CARE FACILITIES, BY TYPE, 2019–2026 (USD MILLION) 45
7.4.1 PHYSICIANS’ OFFICES 45
7.4.1.1 Increasing number of people seeking treatment at physicians’ clinics based on positive online reviews to drive market growth 45
7.4.2 CLINICS 45
7.4.2.1 Growing number of clinics adopting modern approaches to treatment and digitized workflows to drive market growth 45
8 COMPETITIVE LANDSCAPE 46
8.1 OVERVIEW 46
8.2 KEY DEVELOPMENTS 46
FIGURE 14 KEY DEVELOPMENTS BY PROMINENT PLAYERS IN
THE US PATIENT EXPERIENCE TECHNOLOGY MARKET 46
8.3 MARKET RANKING 47
FIGURE 15 US PATIENT EXPERIENCE TECHNOLOGY MARKET RANKING,
BY KEY PLAYER, 2020 47
8.4 COMPANY EVALUATION MATRIX DEFINITION & METHODOLOGY 48
8.4.1 STARS 48
8.4.2 PERVASIVE PLAYERS 48
8.4.3 EMERGING LEADERS 48
8.4.4 PARTICIPANTS 48
FIGURE 16 US PATIENT EXPERIENCE TECHNOLOGY MARKET:
COMPANY EVALUATION QUADRANT, 2020 49
8.5 COMPETITIVE SITUATIONS AND TRENDS 50
8.5.1 PRODUCT LAUNCHES 50
TABLE 8 PRODUCT LAUNCHES, JANUARY 2019–JUNE 2021 50
8.5.2 DEALS 51
TABLE 9 DEALS, JANUARY 2019–JUNE 2021 51
9 COMPANY PROFILES 55
(Business Overview, Products & services Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
9.1 KEY PLAYERS 55
9.1.1 VOCERA COMMUNICATIONS INC. 55
TABLE 10 VOCERA COMMUNICATIONS INC.: BUSINESS OVERVIEW 55
FIGURE 17 VOCERA COMMUNICATIONS INC.: COMPANY SNAPSHOT (2020) 56
9.1.2 PRESS GANEY ASSOCIATES 59
TABLE 11 PRESS GANEY ASSOCIATES: BUSINESS OVERVIEW 59
9.1.3 QUALTRICS INTERNATIONAL INC. 62
TABLE 12 QUALTRICS: BUSINESS OVERVIEW 62
FIGURE 18 QUALTRICS: COMPANY SNAPSHOT (2020) 63
9.1.4 SODEXO 66
TABLE 13 SODEXO: BUSINESS OVERVIEW 66
FIGURE 19 SODEXO: COMPANY SNAPSHOT (2020) 67
9.1.5 HURON CONSULTING GROUP 69
TABLE 14 HURON CONSULTING GROUP: BUSINESS OVERVIEW 69
FIGURE 20 HURON CONSULTING GROUP: COMPANY SNAPSHOT (2020) 69
9.1.6 ARAMARK 71
TABLE 15 ARAMARK: BUSINESS OVERVIEW 71
FIGURE 21 ARAMARK: COMPANY SNAPSHOT (2020) 72
9.1.7 CIPHERHEALTH 74
TABLE 16 CIPHERHEALTH: BUSINESS OVERVIEW 74
9.1.8 ACCENTURE PLC 76
TABLE 17 ACCENTURE PLC: BUSINESS OVERVIEW 76
FIGURE 22 ACCENTURE PLC: COMPANY SNAPSHOT (2020) 77
9.2 OTHER PLAYERS 79
9.2.1 GETWELL NETWORK INC. 79
TABLE 18 GETWELL NETWORK INC.: BUSINESS OVERVIEW 79
9.2.2 HYBRIDCHART INC. 81
TABLE 19 HYBRIDCHART INC.: BUSINESS OVERVIEW 81
*Details on Business Overview, Products & services Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
10 APPENDIX 83
10.1 DISCUSSION GUIDE 83
10.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 85
10.3 AVAILABLE CUSTOMIZATIONS 87
10.4 RELATED REPORTS 87
10.5 AUTHOR DETAILS 88



★調査レポート[アメリカのペイシェント・エクスペリエンス(PX)技術市場(~2026年):コンポーネント別(技術(患者ラウンディング、患者体験調査)、コンサルティングサービス)、施設種類別(急性期治療、急性期後治療、非急性期治療(医師室、クリニック))] (コード:HIT 8057-22)販売に関する免責事項を必ずご確認ください。
★調査レポート[アメリカのペイシェント・エクスペリエンス(PX)技術市場(~2026年):コンポーネント別(技術(患者ラウンディング、患者体験調査)、コンサルティングサービス)、施設種類別(急性期治療、急性期後治療、非急性期治療(医師室、クリニック))]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆